Antibiotics: Examples, Coverage, Side Effects, and Dosages
Antibiotics should be selected based on the suspected pathogen, infection site, local resistance patterns, and patient factors, with a preference for the narrowest spectrum agent effective against the suspected pathogen to minimize resistance development and adverse effects.
Common Antibiotic Classes and Examples
Penicillins
Amoxicillin
- Coverage: Gram-positive cocci (except MRSA), some Gram-negative bacilli
- Dosage: 500 mg PO q8h or 875 mg PO q12h
- Side effects: Rash, diarrhea, hypersensitivity reactions
Amoxicillin-Clavulanate
- Coverage: Extended to include beta-lactamase producing organisms
- Dosage: 875/125 mg PO q12h or 500/125 mg PO q8h; 1.2 g IV q8h 1
- Side effects: Diarrhea, nausea, rash, elevated liver enzymes
Oxacillin/Nafcillin
- Coverage: MSSA infections
- Dosage: 2 g IV q4-6h 2
- Side effects: Phlebitis, neutropenia, hepatotoxicity
Cephalosporins
First Generation
Cefazolin
- Coverage: MSSA, streptococci, some Gram-negative bacilli
- Dosage: 2 g IV q8h 2
- Side effects: Hypersensitivity, seizures at high doses
Cephalexin
- Coverage: Similar to cefazolin but oral
- Dosage: 500 mg PO q6h 2
- Side effects: Diarrhea, nausea, rash
Third Generation
- Ceftriaxone
- Coverage: Broad Gram-negative coverage, streptococci, some anaerobes
- Dosage: 1-2 g IV q24h 1
- Side effects: Gallbladder sludging, hemolytic anemia, diarrhea
Fluoroquinolones
Levofloxacin
Ciprofloxacin
- Coverage: Excellent Gram-negative coverage including Pseudomonas
- Dosage: 400 mg IV q12h or 500-750 mg PO q12h 2
- Side effects: Similar to levofloxacin
Macrolides
- Azithromycin
Tetracyclines
- Doxycycline
- Coverage: Broad spectrum including atypical pathogens and MRSA
- Dosage: 100 mg PO/IV q12h 1
- Side effects: Photosensitivity, GI upset, tooth discoloration in children
Glycopeptides
- Vancomycin
- Coverage: Gram-positive organisms including MRSA
- Dosage: 15-20 mg/kg IV q8-12h 2
- Side effects: Red man syndrome, nephrotoxicity, ototoxicity
Lincosamides
- Clindamycin
- Coverage: Gram-positive cocci, anaerobes
- Dosage: 600 mg IV/PO q8h 2
- Side effects: C. difficile colitis, rash, metallic taste
Oxazolidinones
- Linezolid
- Coverage: MRSA, VRE, resistant pneumococci
- Dosage: 600 mg PO/IV q12h 2
- Side effects: Myelosuppression, peripheral neuropathy, serotonin syndrome
Antibiotic Selection by Infection Type
Skin and Soft Tissue Infections
Impetigo/Cellulitis:
Necrotizing Fasciitis:
- Combination therapy: Vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem 2
Surgical Site Infections:
Respiratory Infections
Community-Acquired Pneumonia:
Hospital-Acquired Pneumonia:
- Anti-pseudomonal β-lactam plus aminoglycoside or fluoroquinolone 2
Atypical Pneumonia:
Genitourinary Infections
Uncomplicated UTI:
- First-line: TMP-SMX, nitrofurantoin
- Alternative: Fluoroquinolones (levofloxacin 250-500 mg daily) 3
Sexually Transmitted Infections:
Special Considerations
Pediatric Patients
- Avoid tetracyclines in children <8 years (dental staining) 1
- Avoid fluoroquinolones in children <18 years (cartilage toxicity) 1
- Dosing: Generally weight-based (mg/kg)
Pregnancy
- Avoid tetracyclines (teratogenic) 1
- Avoid fluoroquinolones (potential teratogenicity) 1
- Preferred: Penicillins, cephalosporins, azithromycin
Renal Impairment
- Require dose adjustment: Aminoglycosides, vancomycin, fluoroquinolones, beta-lactams
Antibiotic Stewardship Principles
- Obtain cultures before starting antibiotics when possible 1
- Use the narrowest spectrum agent effective against the suspected pathogen 1
- Reassess therapy at 48-72 hours based on clinical response and culture results 1
- De-escalate to targeted therapy when possible 1
- Use the shortest effective duration to minimize resistance development 1
Common Pitfalls to Avoid
- Overuse of broad-spectrum antibiotics for uncomplicated infections
- Inadequate dosing leading to treatment failure or resistance
- Prolonged therapy beyond recommended duration
- Failure to adjust therapy based on culture results
- Inappropriate antibiotic selection for the suspected pathogen
Remember that local resistance patterns should guide empiric therapy choices, and treatment should be adjusted based on culture results whenever available.